NorthWest Biotherapeutics Inc (NWBO)

[The Danish Dude]

Agree.

And instead of having released TLD early last year, NWBO has progressed either way with exactly the same stuff, as they should've anyway.

And then came the small feather regarding WHO CNS5, that glioblastomas will comprise only IDH-wildtype tumors.

2021 Top Story in Brain Cancer: The 2021 WHO Classification of Tumors of the Central Nervous System

https://www.practiceupdate.com/content/2021-top-story-in-brain-cancer-the-2021-who-classification-of-tumors-of-the-central-nervous-system/127380/31/12/3

Suddenly NWBO had time to do a small round-the-table event regarding that, peer reviewing the journal and small talking with statisticians, which probably have also had quite a nice impact also on primary endpoints, if I've listened carefully.